American National Registered Investment Advisor’s BioMarin Pharmaceuticals BMRN Stock Holding History

American National Registered Investment Advisor’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$272K	Sell	3,531 -80	-2%	-$6.69K	0.1%	226
2021 Q4	$319K	Sell	3,611 -1	-0%	-$83	0.11%	212
2021 Q3	$279K	Sell	3,612 -10	-0.3%	-$789	0.1%	217
2021 Q2	$302K	Sell	3,622 -20	-0.5%	-$1.58K	0.11%	212
2021 Q1	$275K	Sell	3,642 -3	-0.1%	-$245	0.11%	214
2020 Q4	$320K	Sell	3,645 -80	-2%	-$6.34K	0.13%	181
2020 Q3	$283K	Hold	3,725	–	–	0.13%	169
2020 Q2	$459K	Hold	3,725	–	–	0.23%	128
2020 Q1	$315K	Hold	3,725	–	–	0.2%	145
2019 Q4	$315K	Hold	3,725	–	–	0.16%	178
2019 Q3	$251K	Hold	3,725	–	–	0.14%	188
2019 Q2	$319K	Hold	3,725	–	–	0.18%	168
2019 Q1	$331K	Sell	3,725 -10	-0.3%	-$927	0.18%	170
2018 Q4	$318K	Hold	3,735	–	–	0.2%	152
2018 Q3	$362K	Buy	3,735 +450	+14%	+$44.9K	0.19%	163
2018 Q2	$309K	Hold	3,285	–	–	0.15%	211
2018 Q1	$266K	Sell	3,285 -65	-2%	-$5.58K	0.13%	214
2017 Q4	$299K	Hold	3,350	–	–	0.14%	211
2017 Q3	$312K	Sell	3,350 -940	-22%	-$83.1K	0.16%	206
2017 Q2	$390K	Hold	4,290	–	–	0.16%	204
2017 Q1	$377K	Hold	4,290	–	–	0.16%	209
2016 Q4	$355K	Hold	4,290	–	–	0.16%	202
2016 Q3	$397K	Hold	4,290	–	–	0.19%	184
2016 Q2	$334K	Hold	4,290	–	–	0.16%	205
2016 Q1	$354K	Hold	4,290	–	–	0.17%	191
2015 Q4	$449K	Buy	+4,290	New	+$448K	0.22%	162

Other funds holding BMRN

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

American National Registered Investment Advisor's BMRN Position: Q1 2022 in Review

American National Registered Investment Advisor reduced its BioMarin Pharmaceuticals (BMRN) stake by 2.2% in Q1 2022, selling an estimated $6.69K and leaving 3,531 shares worth $272K. The position accounts for 0.1% of the portfolio, ranked #226.

American National Registered Investment Advisor first reported a position in BMRN in Q4 2015 and has held it in 26 quarters since. The position peaked at $459K in Q2 2020. 560 funds tracked by Wall St. Rank hold BMRN as of Q1 2022.

American National Registered Investment Advisor held 3,531 shares of BioMarin Pharmaceuticals worth $272K as of Q1 2022.
American National Registered Investment Advisor sold 80 BioMarin Pharmaceuticals shares in Q1 2022, an estimated $6.69K.
BioMarin Pharmaceuticals made up 0.1% of American National Registered Investment Advisor's portfolio in Q1 2022, its #226 holding.
American National Registered Investment Advisor first reported a position in BioMarin Pharmaceuticals in Q4 2015 and has held it in 26 quarters since.
American National Registered Investment Advisor's BioMarin Pharmaceuticals position peaked at $459K in Q2 2020.
560 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2022.

Based on American National Registered Investment Advisor's 13F filing for Q1 2022, filed 13 May 2022.